Ripretinib in Patients With Previously Treated Advanced Gastrointestinal Stromal Tumor (GIST): a Prospective, Longitudinal, Multicenter, Observational Study in Germany
Latest Information Update: 07 Oct 2024
At a glance
- Drugs Ripretinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Adverse reactions; Therapeutic Use
- Acronyms INTEREST
- 04 Oct 2024 New trial record